← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

▼ SELL 10b5-1 Plan

$ Value

$124K

Shares

3,523

Price

$35

Filed

Sep 8

Insider

Name

Moat Ross

Title

CHIEF CORP. & COMM. OFFICER

CIK

0001857177

Roles

Officer

Transaction Details

Transaction Date

2025-09-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,415

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.

Filing Info

Accession No.

0001415889-25-023874

Form Type

4

Issuer CIK

0001730430

Moat Ross's History

Date Ticker Type Value
2026-04-09 KNSA $80K
2026-04-07 KNSA M
2026-04-07 KNSA F $38K
2026-04-07 KNSA M $0
2026-04-06 KNSA $115K
2026-04-01 KNSA M
2026-04-01 KNSA F $82K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $1.2M 2026-04-06
Levy Richard S 2026-02-01
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
$1.8M 2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
$2.5M 2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07